Clinical Trial

Endomicroscopic Evaluation of Food-induced Gastrointestinal Mucosal Alteration

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The overarching goal of this study is to establish a first ever registry in the U.S. to collect outcomes data to evaluate changes in the gastrointestinal (GI) mucosa following direct food application utilizing Confocal Laser Endomicroscopy (CLE). This will be assessed in pediatric and adult patients who present to the outpatient clinic with persistent irritable bowel syndrome-like symptoms while testing negative for celiac disease and have either negative or very low/low levels of Immunoglobulin E (IgE) serological tests.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-23.
Trial Details
NCT Number NCT06792838
Lead Sponsor Cook Children's Health Care System
Collaborators: University of Nebraska Medical Center and Children's Hospital & Medical Center, Stanford University, Metrodora Institute, Meliora Bio ApS
Conditions Irritable Bowel Syndrome, Food Allergy
Enrollment 200 participants
Start Date 2025-03
Primary Completion 2033-09 (estimated)
Study Completion 2034-09 (estimated)
Updated on ClinicalTrials.gov 2025-02-24